We are live on ! Find out more
LOAC

Longevity Acquisition Corporation Ordinary Shares
LOAC

Delisted

LOAC was delisted on the 19th of March, 2021.

10 hedge funds and large institutions have $14.4M invested in Longevity Acquisition Corporation Ordinary Shares in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1010 (0)

0% less capital invested

Capital invested by funds: $14.4M → $14.4M (-$46K)

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 3

Holders
10
Holders Change
Holders Change %
0%
% of All Funds
0.2%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
3
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

No buyers this quarter

LOAC Hedge Fund Activity: Q3 2020 in Review

10 of the 4,957 institutional investors tracked by Wall St. Rank reported a position in Longevity Acquisition Corporation Ordinary Shares (LOAC) for Q3 2020, worth a combined $14.4M — down 0.32% from $14.4M a quarter earlier.

Fund positioning in LOAC was balanced in Q3 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 3 trimmed.

The largest seller was Citadel Advisors, cutting an estimated $34.1K.

  • 10 institutional investors held Longevity Acquisition Corporation Ordinary Shares (LOAC) as of Q3 2020, unchanged from Q2 2020.
  • Funds reported $14.4M of Longevity Acquisition Corporation Ordinary Shares stock for Q3 2020, down 0.32% quarter-over-quarter.
  • 0 funds opened new Longevity Acquisition Corporation Ordinary Shares positions in Q3 2020 and 0 closed out.
  • The largest Longevity Acquisition Corporation Ordinary Shares seller in Q3 2020 was Citadel Advisors, an estimated $34.1K sold.

Based on aggregated 13F filings for Q3 2020.